CN114392396B - Rotator cuff patch based on silk fibroin gel and preparation method thereof - Google Patents

Rotator cuff patch based on silk fibroin gel and preparation method thereof Download PDF

Info

Publication number
CN114392396B
CN114392396B CN202210062325.7A CN202210062325A CN114392396B CN 114392396 B CN114392396 B CN 114392396B CN 202210062325 A CN202210062325 A CN 202210062325A CN 114392396 B CN114392396 B CN 114392396B
Authority
CN
China
Prior art keywords
solution
rotator cuff
patch
silk protein
fibroin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202210062325.7A
Other languages
Chinese (zh)
Other versions
CN114392396A (en
Inventor
张韬
刘楠楠
吴冬枝
何文慧
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fuzhou Second Hospital
Original Assignee
Fuzhou Second Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuzhou Second Hospital filed Critical Fuzhou Second Hospital
Priority to CN202210062325.7A priority Critical patent/CN114392396B/en
Publication of CN114392396A publication Critical patent/CN114392396A/en
Application granted granted Critical
Publication of CN114392396B publication Critical patent/CN114392396B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/08—Muscles; Tendons; Ligaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02—Inorganic materials
    • A61L27/025—Other specific inorganic materials not covered by A61L27/04 - A61L27/12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B5/00—Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts
    • B32B5/02—Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts characterised by structural features of a fibrous or filamentary layer
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B5/00—Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts
    • B32B5/22—Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts characterised by the presence of two or more layers which are next to each other and are fibrous, filamentary, formed of particles or foamed
    • B32B5/24—Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts characterised by the presence of two or more layers which are next to each other and are fibrous, filamentary, formed of particles or foamed one layer being a fibrous or filamentary layer
    • B32B5/26—Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts characterised by the presence of two or more layers which are next to each other and are fibrous, filamentary, formed of particles or foamed one layer being a fibrous or filamentary layer another layer next to it also being fibrous or filamentary
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C07K14/43586—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from silkworms
    • D—TEXTILES; PAPER
    • D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
    • D04H—MAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
    • D04H1/00—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres
    • D04H1/70—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres
    • D04H1/72—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres the fibres being randomly arranged
    • D04H1/728—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres the fibres being randomly arranged by electro-spinning
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/08—Muscles; Tendons; Ligaments
    • A61F2002/0894—Muscles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/10—Materials or treatment for tissue regeneration for reconstruction of tendons or ligaments
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B2260/00—Layered product comprising an impregnated, embedded, or bonded layer wherein the layer comprises an impregnation, embedding, or binder material
    • B32B2260/02—Composition of the impregnated, bonded or embedded layer
    • B32B2260/021—Fibrous or filamentary layer
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B2260/00—Layered product comprising an impregnated, embedded, or bonded layer wherein the layer comprises an impregnation, embedding, or binder material
    • B32B2260/04—Impregnation, embedding, or binder material
    • B32B2260/046—Synthetic resin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B2262/00—Composition or structural features of fibres which form a fibrous or filamentary layer or are present as additives
    • B32B2262/08—Animal fibres, e.g. hair, wool, silk
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B2535/00—Medical equipment, e.g. bandage, prostheses, catheter

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Insects & Arthropods (AREA)
  • Textile Engineering (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Materials For Medical Uses (AREA)

Abstract

A rotator cuff patch based on fibroin gel comprises a rotator cuff patch body, a fibroin electrostatic spinning film as a patch base layer, and Mg 2+ The ionic silk protein gel is loaded with anti-inflammatory agent layer and contains Zn 2+ The ionic silk protein gel is loaded with a healing promoting drug layer, has full degradation characteristic, realizes early inhibition of inflammatory reaction, promotes osteogenesis in a repair period, achieves the effect of promoting graft integration, and has higher biological safety.

Description

Rotator cuff patch based on silk fibroin gel and preparation method thereof
Technical Field
The invention belongs to the field of tissue repair, and particularly relates to a rotator cuff patch based on a silk fibroin gel coating, which is used for repairing rotator cuffs, inhibiting the generation and development of inflammation, facilitating further playing a role in promoting healing, and has higher safety, and a method for preparing the patch.
Background
Rotator cuff tears can cause joint pain, reduced function, stiffness and range of motion limitations, and place a huge economic burden on society. Huge rotator cuff tear means that the tear is larger than 5cm or the rotator cuff injury of more than or equal to 2 tendons is affected, and the current treatment is mainly surgical repair. The function of the shoulder joint of some patients after operation is greatly improved, but the re-tearing rate is higher and can reach 15 to 94 percent. The cause of the reoccurrence is related to factors such as tear size, blood supply, fat infiltration, age, smoking, and muscle atrophy. Research shows that the tearing size and the re-tearing are relatively large, because the tension is an important reason for the failure of the rotator cuff repair operation, the operation mode of huge rotator cuff tearing is still a big problem, and a better method needs to be designed to avoid the re-tearing. The rotator cuff patch is used for replacing a defective tendon, and the tensionless or micro-tension repair is considered to be capable of promoting healing and reducing the occurrence of re-tearing.
Currently clinically used rotator cuff patches include autologous fascia lata or quadriceps femoris patches, allogeneic or xenogeneic acellular dermal patches and synthetic material patches (PET, PTFE, PGA, etc.). Autografts are widely used, but have the problem of donor area lesions. Allografts are widely available without sacrificing autologous tissue, but are at risk for foreign body reactions, long healing times, and host-borne disease. The artificial implant has advantages in terms of biomechanics, but has problems such as foreign body reaction or local inflammation. Therefore, improving the performance of the artificial graft, reducing foreign body reaction or inflammatory reaction and promoting the integration of the artificial graft are key scientific problems in the development of artificial patches.
Disclosure of Invention
The invention aims to provide a rotator cuff patch based on silk protein gel, which is a fully degradable patch, promotes the anti-inflammation of damaged tissues and is beneficial to promoting the healing and repairing of the tissues.
The invention also aims to provide a method for preparing the rotator cuff patch based on silk fibroin gel, which slowly releases medicines, healing promoting molecules and the like along with the degradation of silk fibroin, realizes the early inhibition of inflammatory reaction, promotes osteogenesis in a repair period, and achieves the effect of promoting graft integration.
The technical scheme of the invention is as follows:
a rotator cuff patch comprising a rotator cuff patch body, the rotator cuff patch body comprising:
a patch basal layer, which is an electrostatic spinning film made of fibroin;
the anti-inflammatory drug-loaded layer is prepared from fibroin gel and contains Mg 2+ Ions;
a healing-promoting drug-loaded layer made of fibroin gel and containing Zn 2+ Ions;
the anti-inflammatory drug-loaded layer is arranged on the healing promoting drug-loaded layer, and the healing promoting drug-loaded layer is covered on the substrate layer of the patch.
Preferably, the rotator cuff patch further comprises a sewing area arranged around the rotator cuff patch body, and a plurality of sewing holes are formed in the sewing area to be sewn with the part to be repaired.
The preparation method of the rotator cuff patch comprises the following steps:
mixing 15wt% regenerated silk protein solution and 80wt% PEG solution in equal volume, adding divalent zinc ion (such as zinc sulfate), stirring to obtain zinc ion-containing PEG-silk protein solution, and pouring the solution into flat bottom template with thickness of 0.5mm. Soaking the preprocessed silk fibroin electrostatic spinning membrane in a PEG-silk fibroin solution for standing, and incubating at room temperature to naturally gelatinize the surface of the electrostatic spinning membrane to obtain a semi-finished product of the artificial rotator cuff patch;
a mixture solution of 15wt% regenerated silk protein and 80wt% PEG was repeatedly prepared, divalent magnesium ion (e.g., magnesium sulfate) was added thereto, and the mixture was stirred uniformly to prepare a magnesium ion-containing PEG-silk protein solution, which was poured into a flat-bottomed glass mold with a thickness of 1.0mm. And soaking the semi-finished product of the artificial rotator cuff patch in the solution, and incubating at room temperature to naturally gelatinize the surface of the semi-finished product of the artificial rotator cuff patch to obtain a finished product of the artificial rotator cuff patch.
Preferably, in the preparation method of the artificial rotator cuff patch based on silk fibroin gel, the pretreatment of the silk fibroin electrostatic spinning film comprises the following steps:
soaking the fibroin electrostatic spinning membrane (or cutting the fibroin electrostatic spinning membrane into a preset length) in 75wt% ethanol solution, carrying out ultrasonic treatment for 30 minutes, and washing the surface of the fibroin electrostatic spinning membrane with deionized water after the ultrasonic treatment is finished so as to remove impurities on the surface of the fibroin electrostatic spinning membrane;
and drying the cleaned fibroin electrostatic spinning membrane in a vacuum drying oven at room temperature to constant weight.
Preferably, in the preparation method of the artificial rotator cuff patch based on silk fibroin gel, the regenerated silk fibroin solution is prepared by the following steps:
placing the silkworm cocoons in boiling water with the concentration of sodium bicarbonate being 0.5wt% for boiling for 30 minutes, washing with water for three times, boiling for 30 minutes again under the same condition, taking out, washing with warm water for three times, washing with deionized water for 4 times, and drying in an oven at 40 ℃ for 24 hours to obtain the degumming silk;
placing the degummed silk in a lithium bromide aqueous solution with the concentration of 9.3mol/L, heating for 1 hour under the condition of 60 ℃ water bath, filtering the dissolved regenerated silk protein solution by using eight layers of gauze to remove insoluble impurities, pouring the filtered solution into a dialysis bag, and dialyzing for three days in deionized water;
and centrifuging the dialyzed solution at 8000 rpm for 10 minutes at 4-10 ℃, filtering with eight layers of gauze, and removing insoluble impurities to obtain the regenerated silk protein solution.
Preferably, in the preparation method of the artificial rotator cuff patch based on silk protein gel, the concentration of divalent zinc ions in the zinc ion-containing PEG-silk protein solution is 2mg/ml.
Preferably, in the preparation method of the artificial rotator cuff patch based on silk protein gel, the concentration of divalent magnesium and zinc in the magnesium-ion-containing PEG-silk protein solution is 1mg/ml.
The invention has the following beneficial effects:
the outermost layer contains Mg 2+ The release period of the ionic silk protein gel anti-inflammatory drug layer is about 3-5 days, and the inner layer contains Zn 2+ The ionic silk protein gel promotes healing of the drug layer, and the slow release period is about 1-2 weeks;
magnesium ion anti-inflammatory effects are associated with the inhibition of Nitric Oxide (NO) production by activated macrophages. Endogenously produced nitric oxide can induce joint inflammation. Magnesium ions can alleviate arthritic symptoms by interfering with the activation of T lymphocytes and macrophages. The NMDA receptor is a specific ion channel protein and the NMDA receptor subunit NR1 is considered an essential component of all functional receptors. Magnesium ions can inhibit the phosphorylation of NR1, thereby preventing the development of joint inflammation and relieving pain. In short, magnesium ions may prevent the development of joint inflammation by inhibiting the production of NO in the body and inhibiting NMDA receptors, among other pathways. In addition, magnesium ions are thought to induce macrophage polarization in the M2 direction, inhibiting inflammatory responses. The magnesium ions also have good osteogenesis promoting effect, and the magnesium ions play a dual regulation and control role in bone tissue regeneration. During the early inflammatory phase, magnesium ions build up an immune microenvironment that promotes bone tissue regeneration by promoting the recruitment and polarization of monocyte-macrophages [2]. Currently, magnesium-based biomaterials include a large number of magnesium-containing compounds, such as oxides, phosphates and silicates, which are involved in orthopedic applications such as bone cement, bone scaffolds or implant coatings, and research on magnesium phosphate (MgP) materials as substitutes for calcium phosphate for the treatment of bone defects has also received wide attention.
Zinc (Zn) is an essential trace element of the human body, and is usually present in bone tissues, and about 30% of zinc in the body is present in bone tissues. Zinc plays an important role in the formation, development, mineralization and maintenance of healthy bones. In addition, as a medium for skeletal development and growth, zinc deficiency in a human body can cause dwarfism, osteoporosis, skeletal developmental retardation and the like. Previous in vitro studies have shown Zn 2+ Can improve the osteogenesis of stem cells and enhance mineral deposition. Zinc produces a matrix of collagen filaments as a matrix for biomineralization deposition. Zinc has also been found to exchange calcium at sites of bone regeneration, increasing ALP (alkaline phosphatase) activity, which is associated with bone calcification, supporting osteogenic regeneration.Osterix is a zinc-based finger-containing transcription factor, and is reported to proliferate and promote osteogenic differentiation of mesenchymal stem cells, thereby increasing expression of markers associated with osteogenic activity. Divalent zinc ions also inhibit the metabolism and growth of bacteria by interacting with sulfhydryl groups on bacterial enzymes. In addition, zinc in the sugar phosphotransferase system and the ATPase, respectively, inhibits sugar transport and acid tolerance, thereby reducing ATP synthesis in glycolytic cells, resulting in bacterial growth inhibition. Zinc is widely used as an antibacterial agent and a bone-proliferating agent, and plays an important role in the antibacterial of dental implants and the treatment of bone defects and osteoporosis.
In the process of tissue repair, the patch of the invention not only has certain anti-inflammatory effect, but also has full degradation characteristic, and has no foreign body residue in vivo. The combination of gelatin can relieve foreign body reaction caused by the implantation of the patch. Compared with the similar patch (such as a combination of cellulose film and gelatin material), the patch of the invention is more outstanding in promoting osteogenesis.
Additional advantages, objects, and features of the invention will be set forth in part in the description which follows and in part will become apparent to those having ordinary skill in the art upon examination of the following or may be learned from practice of the invention.
Drawings
FIG. 1 is a schematic structural view of one embodiment of an artificial rotator cuff patch provided by the present invention;
FIG. 2 is a graph showing the results of immunohistochemical IL-1 β expression;
fig. 3 is a staining map of the area of the experimental group b of the tendinous bones.
Detailed Description
The present invention is further described in detail below with reference to the attached drawings so that those skilled in the art can implement the invention by referring to the description text.
It will be understood that terms such as "having," "including," and "comprising," as used herein, do not preclude the presence or addition of one or more other elements or groups thereof.
In the rotator cuff patch provided in this example, a fibroin film was formed by electrospinning and used as the base layer of the patch.
The rotator cuff patch was 1mm thick and had three dimensions: 4 × 6 × 1, 4 × 4 × 1,3 × 4 × 1, with a suture region and suture holes around. A belt is arranged on the device, so that the tissue can be plugged in the operation without sewing, and the sticking is mainly performed.
In one embodiment, the rotator cuff patch further comprises a sewing area arranged on the periphery of the rotator cuff patch body, and a plurality of sewing holes are formed in the sewing area to be sewn with a part to be repaired.
In one embodiment, the rotator cuff patch body is further covered with silk fibroin gel for loading molecules (Mg) for inhibiting inflammation 2+ Ions) and healing-promoting molecules (Zn) 2+ Ions).
Example 1 preparation of a Patch
The regenerated silk protein solution is prepared by the following steps:
placing the silkworm cocoons in boiling water with the concentration of sodium bicarbonate being 0.5wt% for boiling for 30 minutes, after washing for three times, boiling for 30 minutes again under the same condition, taking out the silkworm cocoons, washing for three times with warm water, then washing for 4 times with deionized water, and drying in an oven at 40 ℃ for 24 hours to obtain degumming silks;
putting the degummed silk into a lithium bromide aqueous solution with the concentration of 9.3mol/L, heating for 1 hour under the condition of water bath at 60 ℃, filtering the dissolved regenerated silk protein solution by using eight layers of gauze to remove insoluble impurities, pouring the filtered solution into a dialysis bag, and dialyzing for three days in deionized water;
and centrifuging the dialyzed solution at 8000 rpm for 10 minutes at 4-10 ℃, filtering with eight layers of gauze, and removing insoluble impurities to obtain the regenerated fibroin solution.
After the fibroin is prepared into an electrostatic spinning membrane, the following pretreatment is carried out:
shearing the fibroin electrostatic spinning membrane into a preset length, soaking the membrane in 75wt% ethanol solution, carrying out ultrasonic treatment for 30 minutes, and washing the surface of the fibroin electrostatic spinning membrane with deionized water after the ultrasonic treatment is finished so as to remove impurities on the surface of the fibroin electrostatic spinning membrane. And drying the cleaned fibroin electrostatic spinning membrane in a vacuum drying oven at room temperature to constant weight.
Mixing the regenerated silk protein solution with the mass fraction of 15% and the PEG solution with the concentration of 80% in equal volume. Adding medicine zinc sulfate, and stirring uniformly by magnetic force to obtain a mixed solution of zinc sulfate/regenerated silk protein and PEG, wherein the concentration of the zinc sulfate is 5mg/ml (the concentration of divalent zinc is 2 mg/ml). The solution was poured into a flat bottom glass template with a thickness of 0.5mm. Soaking the preprocessed fibroin electrostatic spinning membrane in the solution for standing, incubating for a period of time at room temperature, and naturally gelatinizing the mixed solution on the surface of the electrostatic spinning membrane to obtain a semi-finished product of the artificial rotator cuff patch;
a mixture solution of 15% regenerated silk protein and 80% PEG was prepared repeatedly, magnesium sulfate was added as a drug, and the mixture solution was stirred magnetically to obtain a magnesium sulfate/regenerated silk protein and PEG mixed solution, wherein the concentration of magnesium sulfate was 5mg/ml (divalent zinc concentration 1 mg/ml). The solution was poured into a flat bottom glass template with a thickness of 1.0mm. And soaking the semi-finished product of the artificial rotator cuff patch in the solution, incubating for a period of time at room temperature, and naturally gelling on the surface of the semi-finished product of the artificial rotator cuff patch to obtain a finished product of the artificial rotator cuff patch.
Fig. 1 is a schematic diagram of an embodiment of a patch prepared according to the present invention, which includes a fibroin electrospun membrane as a patch base layer 1, and a first fibroin-loaded anti-inflammatory drug layer 4, a second fibroin-loaded biological factor layer 2, a third fibroin-loaded biological factor layer 3, and a fourth fibroin-loaded anti-inflammatory drug layer 5.
Example 2 Performance testing
Animal experiment grouping: a. silk protein spinning cloth group; b. fibroin spun silk fibroin gel group.
Weaving the patch: the two ends of the patch are woven by sewing threads, so that the patch is used for sewing the residual end of the rotator cuff and the head end of the humerus. The size of the patch after being woven is 10mm in length, 4mm in width and 1mm in thickness, and the patch is suitable for a rabbit infraspinatus tendon suture model. And performing biomechanical test on the sewn patch to meet the maximum requirement of lacerated musculus spinatus of the rabbit of about 130N.
(1) 2.5-3.5kg of New Zealand white rabbit, after anaesthetizing, the shoulder joint is preserved, and an incision of about 4cm is made above the infraspinatus tendon, and the infraspinatus tendon is subjected to blunt dissection layer by layer to expose the infraspinatus tendon. The infraspinatus muscle was resected against the humeral stop and the stump and the bone surface were reshaped.
(2) Making 2 1mm bone channels at the stop point of the humerus head, threading the residual end of the infraspinatus, sewing the suture thread back to the original stop point through the bone channels, sewing one end of the patch with the tendon, and fixing the other end of the patch near the stop point through the bone channels, thereby achieving the purpose of reinforcing and repairing. Suture layer by layer, sterilizing incision, and injecting penicillin.
(3) The cage culture is carried out after the operation, and the activity is not limited. Local anti-inflammatory monitoring (immunohistochemistry), histological observation (HE, masson), infraspinatus fat infiltration, biomechanical testing were performed at 1, 6, 12 weeks after surgery.
Immunohistochemical IL-1. Beta. Expression results in groups a and b after one week are shown in FIG. 2, and immunohistochemical inflammatory responses in group b are low. As shown in fig. 3, cartilage regeneration occurred in the 12 week group b area and the regenerated tissue was more orderly arranged. Biomechanics: maximum pull at 12 weeks: the fibroin spinning fibroin gel group is 142.11 +/-9.73N, and the fibroin spinning is 95.02 +/-8.23N.
While embodiments of the invention have been disclosed above, it is not limited to the applications listed in the description and the embodiments, which are fully applicable in all kinds of fields of application of the invention, and further modifications may readily be effected by those skilled in the art, so that the invention is not limited to the specific details without departing from the general concept defined by the claims and the scope of equivalents.

Claims (5)

1. The application of artificial material based on silk fibroin gel in preparing rotator cuff patch is characterized in that the rotator cuff patch comprises a rotator cuff patch body, and the rotator cuff patch body comprises:
a patch basal layer is formed by electrostatic spinning of fibroin;
loaded with an anti-inflammatory drug layer consisting of Mg 2+ Ionic PEG silk protein solution, said solution containing Mg 2+ Mg in ionic PEG silk protein solution 2+ The ion concentration is 1mg/ml;
loaded with a healing-promoting drug layer consisting of Zn 2+ Ionic PEG silk protein solution gelatinizing, the said Zn-containing 2+ Zn in ionic PEG silk protein solution 2+ The ion concentration is 2mg/ml;
the anti-inflammatory drug-loaded layer is disposed on the healing promoting drug-loaded layer, and the healing promoting drug-loaded layer is coated on the patch substrate layer.
2. The use of claim 1, further comprising a suture region disposed about said rotator cuff patch body and having suture holes therein for suturing with a site to be repaired.
3. The use according to claim 1, wherein the preparation method of the rotator cuff patch comprises the following steps:
mixing 15wt% regenerated silk protein solution and 80wt% PEG solution in equal volume, adding divalent zinc ion, stirring to obtain zinc ion-containing PEG-silk protein solution, pouring the solution into flat bottom template with thickness of 0.5mm; soaking the preprocessed silk fibroin electrostatic spinning membrane in a PEG-silk fibroin solution for standing, and incubating at room temperature to naturally gelatinize the surface of the electrostatic spinning membrane to obtain a semi-finished product of the artificial rotator cuff patch;
repeatedly preparing a mixture solution of 15wt% regenerated silk protein and 80wt% PEG, adding divalent magnesium ions, uniformly stirring to obtain a magnesium ion-containing PEG-silk protein solution, pouring the solution into a flat bottom glass template, wherein the thickness of the solution is 1.0mm, soaking the semi-finished product of the artificial rotator cuff patch in the solution, and incubating at room temperature to naturally gelatinize the surface of the semi-finished product of the artificial rotator cuff patch to obtain a finished product of the artificial rotator cuff patch.
4. The use according to claim 3, wherein the method of pretreating a fibroin electrospun membrane comprises:
soaking the fibroin electrostatic spinning membrane in 75wt% ethanol solution, carrying out ultrasonic treatment, and washing the surface of the fibroin electrostatic spinning membrane with deionized water.
5. The use of claim 3, wherein the regenerated silk protein solution is prepared by the steps of:
putting the degummed silk into a lithium bromide aqueous solution, heating for 1 hour under the water bath condition of 60 ℃, filtering the dissolved regenerated silk protein solution by using eight layers of gauze to remove insoluble impurities, pouring the filtered solution into a dialysis bag, and dialyzing for three days in deionized water; and (3) centrifuging the dialyzed solution at the rotating speed of 8000 rpm for 10 minutes at the temperature of 4-10 ℃, filtering by eight layers of gauze, and removing insoluble impurities again to obtain the regenerated silk protein solution.
CN202210062325.7A 2022-01-19 2022-01-19 Rotator cuff patch based on silk fibroin gel and preparation method thereof Active CN114392396B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210062325.7A CN114392396B (en) 2022-01-19 2022-01-19 Rotator cuff patch based on silk fibroin gel and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210062325.7A CN114392396B (en) 2022-01-19 2022-01-19 Rotator cuff patch based on silk fibroin gel and preparation method thereof

Publications (2)

Publication Number Publication Date
CN114392396A CN114392396A (en) 2022-04-26
CN114392396B true CN114392396B (en) 2022-10-28

Family

ID=81231234

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210062325.7A Active CN114392396B (en) 2022-01-19 2022-01-19 Rotator cuff patch based on silk fibroin gel and preparation method thereof

Country Status (1)

Country Link
CN (1) CN114392396B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114533231B (en) * 2022-04-27 2022-11-29 杭州锐健马斯汀医疗器材有限公司 Balloon body and preparation method and application thereof

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010036992A2 (en) * 2008-09-26 2010-04-01 Trustees Of Tufts College Active silk muco-adhesives, silk electrogelation process, and devices
CN102302801A (en) * 2011-09-14 2012-01-04 上海市第六人民医院 Silk-fibroin-coated polypropylene mesh and preparation method thereof
CN108404204A (en) * 2018-04-17 2018-08-17 苏州丝美特生物技术有限公司 Silk fibroin hydrogel
CN113171224A (en) * 2021-04-08 2021-07-27 浙江大学 Implanted bandage for promoting bone injury repair and preparation method thereof
CN214761617U (en) * 2020-12-12 2021-11-19 河南驼人医疗器械研究院有限公司 Hernia patch with anti-tissue proliferation function
CN113908338A (en) * 2021-08-30 2022-01-11 上海曜爱生物科技有限公司 Preparation method of silk fibroin biological patch

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010036992A2 (en) * 2008-09-26 2010-04-01 Trustees Of Tufts College Active silk muco-adhesives, silk electrogelation process, and devices
CN102302801A (en) * 2011-09-14 2012-01-04 上海市第六人民医院 Silk-fibroin-coated polypropylene mesh and preparation method thereof
CN108404204A (en) * 2018-04-17 2018-08-17 苏州丝美特生物技术有限公司 Silk fibroin hydrogel
CN214761617U (en) * 2020-12-12 2021-11-19 河南驼人医疗器械研究院有限公司 Hernia patch with anti-tissue proliferation function
CN113171224A (en) * 2021-04-08 2021-07-27 浙江大学 Implanted bandage for promoting bone injury repair and preparation method thereof
CN113908338A (en) * 2021-08-30 2022-01-11 上海曜爱生物科技有限公司 Preparation method of silk fibroin biological patch

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
"丝素蛋白基复合水凝胶的研究进展";郭小兰等;《丝绸》;20200515;第45-51页 *

Also Published As

Publication number Publication date
CN114392396A (en) 2022-04-26

Similar Documents

Publication Publication Date Title
CN108310467B (en) Assembled cell-derived extracellular matrix membrane composite bone repair material and preparation method and application thereof
Kirker-Head et al. BMP-silk composite matrices heal critically sized femoral defects
Fang et al. In vitro and in vivo research on using Antheraea pernyi silk fibroin as tissue engineering tendon scaffolds
JP4572009B2 (en) Compositions and methods for repairing neurological tissue
CN104474589A (en) Guided tissue regeneration membrane as well as preparation method and application thereof
WO2010081408A1 (en) Bioactive tissue regeneration film and preparation method thereof
WO2015074176A1 (en) Hydrophilic electrospinning biological composite stent material used for tissue regeneration and preparation method and application thereof
CN113786516B (en) PCL/Col/MC gradient three-layer artificial periosteum and preparation method and application thereof
CN111150882B (en) Silver nanowire-mineralized collagen co-assembled bionic scaffold and preparation method and application thereof
US9421229B2 (en) Neural scaffolds
US20230069580A1 (en) Chemically cross-linked hydrogel and its microspheres, preparation method and application
CN110665055B (en) Sericin/nano-hydroxyapatite tissue engineering bone graft and preparation method and application thereof
CN114392396B (en) Rotator cuff patch based on silk fibroin gel and preparation method thereof
Wu et al. Electrospun fibers immobilized with BMP-2 mediated by polydopamine combined with autogenous tendon to repair developmental dysplasia of the hip in a porcine model
Tang et al. Hard tissue compatibility of natural hydroxyapatite/chitosan composite
CN114732948A (en) Rotator cuff patch and preparation method thereof
Lv et al. Hemostasis-osteogenesis integrated Janus carboxymethyl chitin/hydroxyapatite porous membrane for bone defect repair
CN112999424B (en) Composite electrospun membrane for promoting healing of aponeurosis as well as preparation method and application thereof
CN114377201A (en) Rotator cuff patch based on cellulose gelatin coating and preparation method thereof
CN114699553B (en) Preparation method of 3D printed surface composite coating titanium mesh
CN113633825B (en) Preparation method and application of bFGF-loaded heparinized acellular fat material
CN114404670A (en) Rotator cuff patch based on polyethylene and collagen coating and preparation method thereof
CN114533959A (en) Tendon repair material, preparation method and application in preparation of tendon repair product
Li et al. 3D printed hydroxyapatite/silk fibroin/polycaprolactone artificial bone scaffold and bone tissue engineering materials constructed with double-transfected bone morphogenetic protein-2 and vascular endothelial growth factor mesenchymal stem cells to repair rabbit radial bone defects
CN111921014A (en) Rehmannia polysaccharide/heterogenous calcined bone composite bone repair material

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant